Cancers, Vol. 13, Pages 6351: Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers

Cancers, Vol. 13, Pages 6351: Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers Cancers doi: 10.3390/cancers13246351 Authors: Hiroshi Yoshida Kouya Shiraishi Tomoyasu Kato Cervical cancer is the fourth most common cancer in women worldwide and is predominantly caused by infection with human papillomavirus (HPV). However, a small subset of cervical cancers tests negative for HPV, including true HPV-independent cancers and false-negative cases. True HPV-negative cancers appear to be more prevalent in certain pathological adenocarcinoma subtypes, such as gastric- and clear-cell-type adenocarcinomas. Moreover, HPV-negative cervical cancers have proven to be a biologically distinct tumor subset that follows a different pathogenetic pathway to HPV-associated cervical cancers. HPV-negative cervical cancers are often diagnosed at an advanced stage with a poor prognosis and are expected to persist in the post-HPV vaccination era; therefore, it is important to understand HPV-negative cancers. In this review, we provide a concise overview of the molecular pathology of HPV-negative cervical cancers, with a focus on their definitions, the potential causes of false-negative HPV tests, and the histology, genetic profiles, and pathogenesis of HPV-negative cancers.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research